ReviewCancers2023

Neoadjuvant Immunotherapy for Patients with dMMR/MSI-High Gastrointestinal Cancers: A Changing Paradigm.

Muhammet Ozer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.